ACUS (Acusphere) Valuation Rank

View and export this data going back to 2003. Start your Free Trial

What is Acusphere Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Acusphere Valuation Rank Related Terms

Thank you for viewing the detailed overview of Acusphere's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Acusphere Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Acusphere Inc (OTCPK:ACUS) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

99 Hayden Avenue, Suite 385, Lexington, MA, USA, 02421

Website

http://www.acusphere.com

Acusphere Inc is a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using its proprietary microparticle technology.

Executives

Martyn D Greenacre	director	41 MOORES ROAD, FRAZER PA 19355
Garen G Bohlin	director	C/O PRAECIS PHARMACEUTICALS INC, 830 WINTER STREET, WALTHAM MA 02451
Sandra L Fenwick	director	C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Frederick W Ahlholm	officer: VP Finance	C/O MINERVA NEUROSCIENCES, INC., 1601 TRAPELO ROAD, SUITE 286, WALTHAM MA 02451
John F Thero	other: Former Senior VP/CFO	C/O AMARIN PHARMA, INC., 1430 ROUTE 6, BEDMINSTER NJ 07921
Kate Mitchell	director	950 TOWER LANE, STE 700, FOSTER CITY CA 94404
Bank Of America Corp /de/	10 percent owner	BANK OF AMERICA CORPORATE CENTER, 100 N TRYON ST, CHARLOTTE NC 28255
Bank Of America Na	10 percent owner	100 N. TRYON STREET, CHARLOTTE NC 28255
Nb Holdings Corp	10 percent owner	100 NORTH TRYON STREET, CHARLOTTE NC 28255
Terrance Mcguire	director	C/O POLARIS VENTURE PARTNERS LP, 1000 WINTER STREET, SUITE 3350, WALTHAM MA 02154